Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 10, 2026 03:00 ET | Source: Kainova Therapeutics

Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Kainova Therapeutics announces a $32M CAD first close of its Series B financing, led by Investissement Québec with participation from existing investors.